Transglutaminase Inhibitors to Unlock Their Therapeutic Potential in Diseases
Amerigo Scientific releases transglutaminase inhibitors designed to advance research into their therapeutic applications across a range of diseases. These transglutaminase inhibitors seek to enable ground-breaking findings in a number of domains, such as autoimmune illnesses, neurological diseases, and cancer research. “We recognize the urgent need for effective research tools that can shed light on…